Post-transplantation high-dose cyclophosphamide (Cy) is effective single agent GVHD prophylaxis that permits prompt immune reconstitution after myeloablative HLA matched related and unrelated bone marrow transplantation (BMT)

被引：13
|
作者：
Luznik, L. [1 ]
Fuchs, E. J. [1 ]
Chen, A. R. [1 ]
Kaup, M. [1 ]
Bright, E. C. [1 ]
Bolanos-Meade, J. [1 ]
Hess, A. D. [1 ]
Jones, R. J. [1 ]
机构：
[1] Sidney Kimmel Comprehens Canc Ctr, Div Hematol Malignancies, Baltimore, MD USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2007年 / 13卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2006.12.008
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
6
引用
收藏
页码：4 / 4
页数：1
相关论文
共 50 条
  • [1] Post-transplantation high-dose cyclophosphamide (Cy) is effective single agent GVHD prophylaxis that permits prompt immune reconstitution after myeloalblative HLA matched related and unrelated bone marrow transplantation (BMT).
    Leo, Luznik
    Allen, Chen R.
    Michele, Kaup
    Emilie, Bright C.
    Javier, Bolanos-Meade
    Christopher, Thorburn J.
    Ferdynand, Kos
    Allan, Hess D.
    Richard, Jones J.
    Ephraim, Fuchs J.
    [J]. BLOOD, 2006, 108 (11) : 818A - 819A
  • [2] Post-transplantation cyclophosphamide (Cy) as a single agent for GVHD prophylaxis after HLA matched related and unrelated bone marrow transplantation
    Luznik, L
    Chen, A
    Fuchs, EJ
    Phelps, M
    Crawford, A
    Brodsky, RA
    Huff, CA
    Jones, RJ
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (02) : 26 - 26
  • [3] Post-Transplantation High Dose Cyclophosphamide (Cy) Is Effective Single Agent for Prevention of Acute and Chronic Graft Versus Host Disease after Myeloablative HLA Matched Related and Unrelated Bone Marrow Transplantation (BMT)
    Luznik, Leo
    Bolanos-Meade, Javier
    Brodsky, Robert
    Smith, B. Douglas
    Huff, Carol A.
    Kaup, Michele
    Chen, Allen
    Ambinder, Richard F.
    Jones, Richard J.
    Fuchs, Ephraim J.
    [J]. BLOOD, 2008, 112 (11) : 28 - 28
  • [4] HLA-haploidentical bone marrow transplantation with high-dose post-transplantation cyclophosphamide (Cy)
    Busca, A.
    Bruno, B.
    Giaccone, L.
    Festuccia, M.
    Testa, F.
    Allione, B.
    D'Ardia, S.
    Dellacasa, C.
    Pecoraro, C.
    Marmont, F.
    Falda, M.
    [J]. BONE MARROW TRANSPLANTATION, 2013, 48 : S185 - S185
  • [5] SECONDARY SYSTEMIC IMMUNOSUPPRESSANTS (SSI) AFTER MYELOABLATIVE HLA MATCHED RELATED AND UNRELATED BONE MARROW TRANSPLANTATION (BMT) USING HIGH DOSE CYCLOPHOSPHAMIDE (HICY) AS SOLE GVHD PROPHYLAXIS
    Durakovic, N.
    Meade, Bolanos J.
    Zahurak, M.
    Kowalski, J.
    Fuchs, E. J.
    Jones, R. J.
    Luznik, L.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S161 - S162
  • [6] Comparison of the GVHD prophylaxis with single-agent post-transplantation cyclophosphamide or calcineurin inhibitors in matched related bone marrow transplantation
    Moiseev, Ivan
    Pirogova, Olga
    Babenko, Elena
    Gindina, Tatyana
    Darskaya, Elena
    Morozova, Elena
    Bondarenko, Sergey
    Afanasyev, Boris
    [J]. BONE MARROW TRANSPLANTATION, 2018, 53 : 70 - 71
  • [7] Low Incidence of Severe Mucositis After Myeloablative, HLA-Matched Bone Marrow Transplantation and High Dose, Post-Transplantation Cyclophosphamide
    Ying, Wendy
    Douglas, Tracy T.
    Durakovic, Nadira
    Brovitz-Palmer, Sallie
    Thomas, Lindsey Lombardi
    Jones, Richard J.
    Luznik, Leo
    Fuchs, Ephraim J.
    [J]. BLOOD, 2011, 118 (21) : 408 - 408
  • [8] Post-Transplantation High Dose Cyclophosphamide As Gvhd Prophylaxis in 9/10 HLA-Matched Unrelated Donors Hematopoietic Stem Cell Transplantation
    Mehta, Rohtesh S.
    Saliba, Rima M.
    Chen, Julianne
    Rondon, Gabriela
    Hammerstrom, Aimee E.
    Alousi, Amin M.
    Qazilbash, Muzaffar H.
    Bashir, Qaiser
    Ahmed, Sairah
    Popat, Uday R.
    Hosing, Chitra M.
    Khouri, Issa F.
    Shpall, Elizabeth J.
    Champlin, Richard E.
    Ciurea, Stefan O.
    [J]. BLOOD, 2015, 126 (23)
  • [9] HLA-haploidentical blood or marrow transplantation with high-dose, post-transplantation cyclophosphamide
    Fuchs, E. J.
    [J]. BONE MARROW TRANSPLANTATION, 2015, 50 : S31 - S36
  • [10] Extended Follow-up of Myeloablative, HLA-Matched Allogeneic BMT with High-Dose, Post-Transplantation Cyclophosphamide (PTCy) As Sole GVHD Prophylaxis: Favorable Outcomes Despite Low Incidence of Chronic GVHD
    Kanakry, Christopher G.
    Tsai, Hua-Ling
    Bolanos-Meade, Javier
    Smith, B. Douglas
    Gojo, Ivana
    Kasamon, Yvette L.
    Kanakry, Jennifer A.
    Zahurak, Marianna
    Fuchs, Ephraim J.
    Jones, Richard J.
    Luznik, Leo
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : S37 - S37
12345